Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, October 27, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Steve Valiquette Maintained (TDOC) at Hold with Decreased Target to $32 on, Oct 27th, 2022
Steve Valiquette of Barclays, Maintained "Teladoc Health, Inc." (TDOC) at Hold with Decreased Target from $33 to $32 on, Oct 27th, 2022.
Steve has made no other calls on TDOC in the last 4 months.
There are 14 other peers that have a rating on TDOC. Out of the 14 peers that are also analyzing TDOC, 10 agree with Steve's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Sandy Draper of "Guggenheim" Upgraded from Strong Sell to Hold on, Monday, October 24th, 2022
- Jailendra Singh of "Truist Securities" Maintained at Hold with Decreased Target to $29 on, Friday, October 21st, 2022
- George Hill of "Deutsche Bank" Maintained at Hold with Decreased Target to $31 on, Tuesday, September 27th, 2022
- Scott Schoenhaus of "Keybanc" Initiated at Hold on, Friday, September 16th, 2022
- Ravi Misra of "Berenberg" Downgraded from Strong Buy to Hold and Decreased Target to $35 on, Tuesday, August 2nd, 2022
- Charles Rhyee of "Cowen & Co." Downgraded from Buy to Hold and Decreased Target to $34 on, Tuesday, August 2nd, 2022
- Cindy Motz of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $36 on, Thursday, July 28th, 2022
- Ryan MacDonald of "Needham" Downgraded from Strong Buy to Hold on, Thursday, July 28th, 2022
- Stephanie Davis Demko of "SVB Leerink" Maintained at Hold with Decreased Target to $34 on, Thursday, July 28th, 2022
- David Grossman of "Stifel" Maintained at Hold with Decreased Target to $36 on, Wednesday, June 29th, 2022
These are the ratings of the 4 analyists that currently disagree with Steve
- Robert Simmons of "DA Davidson" Maintained at Strong Buy with Decreased Target to $40 on, Tuesday, October 25th, 2022
- Sean Dodge of "RBC Capital" Maintained at Buy with Decreased Target to $35 on, Wednesday, September 28th, 2022
- Jessica Tassan of "Piper Sandler" Maintained at Buy with Decreased Target to $40 on, Thursday, July 28th, 2022
- Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $55 on, Thursday, July 28th, 2022
